Dengue Fever Management and Treatment
The management of dengue fever primarily involves supportive care with careful fluid management using crystalloid solutions (5-10 ml/kg/hour), acetaminophen for symptom relief, close monitoring for warning signs, and avoidance of aspirin and NSAIDs due to bleeding risk. 1
Diagnosis
Clinical Presentation
- Consider dengue testing in patients with:
Laboratory Testing
- First-line: Dengue virus nucleic acid amplification tests (NAATs) on serum 1
- Acute phase: RT-PCR for viral RNA or NS1 antigen detection 1
- Convalescent phase: IgM antibody detection or demonstration of fourfold rise/fall in antibody titers 1
- Supporting findings: thrombocytopenia, leukopenia, elevated hematocrit, elevated liver enzymes 1
Treatment Algorithm
1. Initial Assessment and Classification
- Assess for warning signs:
- Abdominal pain/tenderness
- Persistent vomiting
- Clinical fluid accumulation
- Mucosal bleeding
- Lethargy/restlessness
- Liver enlargement
- Increasing hematocrit with decreasing platelets 1
2. Fluid Management
For non-severe dengue without warning signs:
- Oral rehydration therapy
- Regular monitoring of vital signs and urine output
For dengue with warning signs or severe dengue:
- Start crystalloid fluids (normal saline or Ringer's lactate) at 5-10 ml/kg/hour 1
- Adjust rate based on clinical response rather than fixed protocols 1
- Monitor vital signs every 15-30 minutes during rapid fluid administration 1
- For dengue shock syndrome (DSS), consider colloids if inadequate response to crystalloids 2, 3
3. Symptom Management
- Use acetaminophen for fever and pain relief 1
- Avoid aspirin and NSAIDs due to increased bleeding risk 1
4. Monitoring
- Document weight accurately
- Monitor vital signs including pulse pressure
- Check baseline hematocrit
- Measure urine output
- Assess respiratory status 1
5. Warning Signs of Fluid Overload
- Increasing respiratory rate with normal/falling hematocrit
- New crackles on lung examination
- Rising JVP
- New onset hepatomegaly
- Peripheral edema 1
6. Special Populations
- Children: Require closer monitoring, more susceptible to fluid overload 1
- Pregnant women: Higher risk of complications, require intensive surveillance 1
- Older adults: Higher risk of severe dengue due to comorbidities 1
Discharge Criteria
- No fever for 48 hours without antipyretics
- Improving clinical status
- Increasing platelet count
- Stable hematocrit
- No respiratory distress
- Good urine output 1
Common Pitfalls and Caveats
Fluid Management Pitfalls:
Medication Errors:
- Using NSAIDs or aspirin can increase bleeding risk 1
- Solution: Use only acetaminophen for fever and pain management
Monitoring Failures:
- Missing early warning signs of deterioration or fluid overload 1
- Solution: Implement systematic monitoring of vital signs, hematocrit, and urine output
Delayed Recognition of Severe Disease:
- Failing to identify progression to dengue hemorrhagic fever or shock syndrome 4
- Solution: Monitor for warning signs and have low threshold for hospitalization when present
Infection Control Oversight:
- Not protecting patients from further mosquito exposure can lead to transmission 1
- Solution: Use mosquito nets and repellents even during hospitalization
The evidence suggests that most patients with dengue can be managed successfully with careful monitoring and appropriate fluid therapy. While there is ongoing research into antiviral treatments, current management remains primarily supportive 5. Early recognition of warning signs and prompt intervention are critical to preventing progression to severe disease and reducing mortality.